Related Experiment Video
Updated: May 6, 2026

07:24
Visible-light Induced Reduction of Graphene Oxide Using Plasmonic Nanoparticle
Published on: September 22, 2015
14.5K
Graphene Oxide: Preparation and Medical Research
Xulong Huang1, Wengang Zhao1, Farid Khalilov1
1College of Life and Environmental Science, Wenzhou University, Wenzhou 325035, China.
Materials (Basel, Switzerland)
|June 27, 2025
Summary
Graphene oxide (GO) shows promise for wound healing and drug delivery due to its properties. Chemical modifications are being developed to improve GO
Area of Science:
- Biomaterials Science
- Nanotechnology
- Materials Chemistry
Background:
- Graphene oxide (GO) possesses unique physicochemical properties, including large surface area and drug-loading capacity.
- These properties enable applications in wound healing, targeted drug delivery, and antimicrobial therapies.
- However, GO's clinical translation is hindered by concerns regarding cytotoxicity, biocompatibility, and potential pathological effects.
Purpose of the Study:
- To provide a comprehensive overview of graphene oxide's antibacterial mechanisms.
- To highlight recent advancements in chemical modification strategies for GO.
- To critically examine the advantages and limitations of GO for biomedical applications, particularly in wound healing and drug delivery.
Main Methods:
- Review of existing literature on graphene oxide's properties and applications.
- Analysis of antibacterial mechanisms of GO.
- Examination of surface functionalization, covalent crosslinking, and incorporation into biocompatible matrices.
- Assessment of chemical modification approaches to enhance GO efficacy and reduce toxicity.
Main Results:
- Graphene oxide exhibits significant potential in biomedical fields due to its inherent properties.
- Surface functionalization and integration into biocompatible matrices are key strategies to enhance GO performance and mitigate toxicity.
- Chemical modifications are improving GO's efficacy in wound healing and drug delivery applications.
Conclusions:
- Graphene oxide offers a versatile platform for advanced therapeutic systems.
- Further research into GO's biological interactions and targeted modifications is crucial for safe clinical translation.
- Developing strategies to enhance GO's performance while minimizing adverse effects is essential for its effective integration into medical treatments.
More Related Videos
Related Concept Videos
Preparation of Amines: Reduction of Oximes and Nitro Compounds
3.7K
Oximes can be reduced to primary amines using catalytic hydrogenation, hydride reduction, or sodium metal reduction. The reduction of aliphatic and aromatic nitro compounds to primary amines takes place by either catalytic hydrogenation or by using active metals like Fe, Zn, and Sn in the presence of an acid.
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
3.7K
Observational Studies
8.9K
Observational studies are a type of analytical study where researchers observe events without any interventions. In other words, the researcher does not influence the response variable or the experiment's outcome.
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
8.9K
Phase I Oxidative Reactions: Overview
1.0K
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
1.0K
Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems
601
Oxidative reactions are pivotal in metabolizing numerous compounds, including pharmaceutical drugs. These reactions often occur in carbon-heteroatom systems, such as carbon-nitrogen, carbon-sulfur, and carbon-oxygen.
In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative...
In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative...
601

